Skip to Content
Merck
CN
  • Severe hypoglycaemia from repaglinide-brotizolam drug interaction: a case report and literature review.

Severe hypoglycaemia from repaglinide-brotizolam drug interaction: a case report and literature review.

Diabetic medicine : a journal of the British Diabetic Association (2012-03-15)
M Khamaisi
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Repaglinide, ≥98% (HPLC), solid
Repaglinide, European Pharmacopoeia (EP) Reference Standard
Repaglinide for system suitability, European Pharmacopoeia (EP) Reference Standard